Compare HMY & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HMY | ALGN |
|---|---|---|
| Founded | 1950 | 1997 |
| Country | South Africa | United States |
| Employees | 34350 | N/A |
| Industry | Precious Metals | Industrial Specialties |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 12.0B |
| IPO Year | N/A | 2000 |
| Metric | HMY | ALGN |
|---|---|---|
| Price | $16.51 | $173.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $16.00 | ★ $192.40 |
| AVG Volume (30 Days) | ★ 5.0M | 1.1M |
| Earning Date | 02-04-2016 | 04-29-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $37.77 | $5.80 |
| Revenue Next Year | $28.06 | $4.59 |
| P/E Ratio | ★ $15.60 | $30.91 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $13.03 | $122.00 |
| 52 Week High | $26.04 | $208.31 |
| Indicator | HMY | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 49.65 |
| Support Level | $16.06 | $159.99 |
| Resistance Level | $21.83 | $183.34 |
| Average True Range (ATR) | 0.70 | 6.80 |
| MACD | 0.46 | 0.32 |
| Stochastic Oscillator | 71.56 | 47.53 |
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.